Components of Immune Function Studied with Lymphoid Tumors

References

• Kindt T. J., Capra J. D. The Antibody Enigma. Plenum, New York 1984; 270
   Google Scholar
• Eisen H. N., Little J. R., Osterland C. K., Simms E. S. A Myeloma Protein with Antibody Activity. Cold Spring Harbor Symp. Quant. Biol. 1967; 32: 75
   Google Scholar
• Potter M. Antigen-binding Myeloma Proteins of Mice. Adv. Immunol. 1977; 25: 141
   PubMed Web of Science ®Google Scholar
• Kohler G., Milstein C. Continuous Cultures of Fused Cells Secreting Antibodies of Predefined Specifications. Nature 1975; 256: 495
   PubMed Web of Science ®Google Scholar
• Hozumi N., Tonegawa S. Evidence for Somatic Rearrangement of Immunoglobulin Genes Coding for Variable and Constant Regions. Proc. Natl. Acad. Sci. USA 1976; 73: 3628
   PubMed Web of Science ®Google Scholar
• Erikson J., Finan J., Nowell P. C., Croce C. M. Translocation of Immunoglobulin VK Genes in Burkitt Lymphoma. Proc. Natl. Acad. Sci. USA 1982; 79: 5611
   PubMed Web of Science ®Google Scholar
• Early P., Rogers J., Davis M., Calame K., Bond M., Wall R., Hood L. Two mRNA Can Be Produced from a Single Immunoglobulin μ Gene by Alternative RNA Processing Pathways. Cell 1980; 20: 313
   PubMed Web of Science ®Google Scholar
• Alt F. W., Bothwell A. L. M., Knapp M., Siden E., Mather E., Koshland M., Baltimore D. Synthesis of Secreted and Membrane-bound Immunoglobulin mu Heavy Chains is Directed by mRNAs that Differ at Their 3′ End. Cell 1980; 20: 293
   PubMed Web of Science ®Google Scholar
• Kuehl W. Synthesis of Immunoglobulin in Myeloma Cells. Curr. Top. Microbiol. Immunol. 1977; 76: 1
   Google Scholar
• Kikutani H., Sitia R., Good R. A., Stavenezer J. Synthesis and Processing of the α Heavy Chains of Secreted and Membrane-bound IgA. Proc. Natl. Acad. Sci. USA 1981; 78: 6426
   Google Scholar
• Wall R., Kuehl M. Biosynthesis and Regulation of Immunoglobulins. Ann. Rev. Immunol. 1983; 1: 393
   PubMed Web of Science ®Google Scholar
• Parslow T. G., Blair D. L., Murphy W. J., Granner D. K. Structure of the 5′ Ends of Immunoglobulin Genes: A Novel Conserved Sequence. Proc. Natl. Acad. Sci. USA 1984; 81: 2650
   PubMed Web of Science ®Google Scholar
• Stavnezer J., Sirlin S., Abbott J. Induction of Immunoglobulin Isotype Switching in Cultured I. 29 B Lymphoma Cells. Characterization of the Accompanying Rearrangements of Heavy Chain Genes. J. Exp. Med. 1985; 161: 577
   PubMed Web of Science ®Google Scholar
• Lynch R. G., Rohrer J. W., Odermatt B. O., Gebel H. M., Autry J. R., Hoover R. G. Immunoregulation of Murine Myeloma Cell Growth and Differentiation: A Monoclonal Model of B cell Differentiation. Immunol. Rev. 1979; 48: 45
   PubMed Web of Science ®Google Scholar
• Vancopoulos G. D., Alt F. W. Regulation of the Assembly and Expression of Variable-Region Genes. Ann. Rev. Immunol. 1986; 4: 339
   Google Scholar
• Lanier L. L., Warner N. L., Ledbetter J. A., Herzenberg L. A. Expression of Lyt-1 Antigen on Certain B Cell Lymphomas. J. Exp. Med. 1981; 153: 988
   Google Scholar
• Hayakawa K., Hardy R. R., Parks D. R., Herzenberg L. A. The “Ly-1 B” Cell Subpopulation in Normal, Immunodefective, and Autoimmune Mice. J. Exp. Med. 1983; 157: 202
   PubMed Web of Science ®Google Scholar
• Mercolino T. J., Arnold L. W., Haughton G. Phosphatidyl Choline Is Recognized by a Series of Ly1+ Murine B Cell Lymphomas Specific for Erythrocyte Membranes. J. Exp. Med. 1986; 163: 155
   PubMed Web of Science ®Google Scholar
• Seligmann M., Mihaesco E., Preud'homme J., Danon F., Brouetx J. Heavy Chain Diseases: Current Findings and Concepts. Immunol Rev. 1979; 48: 145
   PubMed Web of Science ®Google Scholar
• Dreyer W. N., Bennett J. C. The Molecular Basis of Antibody Formation: A Paradox. Proc. Natl. Acad. Sci. USA 1965; 54: 864
   PubMed Web of Science ®Google Scholar
• Baumann B., Potask M. J., Kohler G. Consequences of Frameshift Mutations at the Immunoglobulin Heavy Chain Locus of the Mouse. EMBO Journal 1985; 4: 351
   PubMed Web of Science ®Google Scholar
• Sato H. E., Boyer A., Aoki T., Iritani C., Old L. J. Leukemia-associated Transplantation Antigens Related to Murine Leukemia Virus. The X. 1 System: Immune Response Controlled by a Locus Linked to H-2. J. Exp. Med 1973; 138: 593
   Google Scholar
• Sitia R., Rubartelli A. A., Haemmerling U. Expression of 2 Immunoglobulin Isotypes, IgM and IgA, with Identical Idiotype in the B Cell Lymphoma I. 29. J. Immunol 1981; 127: 1388
   PubMedGoogle Scholar
• Stavenezer J., Marcu K. B., Sirlin S., Alhadiff B., Haemmerling U. Rearrangements and Deletions of Immunoglobulin Heavy Chain Genes in the Double Producing B Cell Lymphoma I. 29. Mol. Cell. Biol. 1982; 2: 1002
   Google Scholar
• Stavenezer J., Abbott J., Sirlin S. Immunoglobulin Heavy Chain Switching in Cultured I. 29 Murine B-Lymphoma Cells: Commitment to an IgA or IgE Switch. Curr. Top. Microbiol. Immunol. 1984; 113: 109
   Google Scholar
• Vogler L. B., Preud-Homme J. L., Seligmann M., Gathings W. E., Crist W. M., Cooper M. D., Bollum F. J. Diversity of Immunoglobulin Expression in Leukaemic Cells Resembling B-lymphocyte Precursors. Nature 1981; 290: 339
   Google Scholar
• Sablitsky F., Radbruch A., Rajewsky K. Spontaneous Immunoglobulin Class Switching in Myeloma and Hybridoma Cell Lines Differs from Physiological Class Switching. Immunol. Rev. 1982; 67: 59
   PubMedGoogle Scholar
• Sitia R., Rubartelli A., Deambrosis S., Pozzi D., Hammerling U. Differentiation in the B Cell Lymphoma I. 29: Inductive Capacities of Lipopolysaccharide and Mycoplasma Fermentans Products. Eur. J. Immunol. 1985; 15: 570
   PubMed Web of Science ®Google Scholar
• Sitia R., Rubartelli A., Kikutani H., Hammerling U., Stavnezer J. The Regulation of Membrane-bound and Secrected Alpha Chain Biosynthesis During the Differentiation of the B Cell Lymphoma I. 29. J. Immunol. 1985; 135: 2859
   Google Scholar
• Fu S. M., Chiorazzi N., Kunkel H. G. Differentiative Capability and Other Properties of the Leukemia Cells of Chronic Lymphocyte Leukemia. Immunol Rev. 1979; 48: 23
   PubMed Web of Science ®Google Scholar
• Paige C. J., Kincaide P. W., Ralph P. Murine B Cell Leukemia Line with Inducible Surface Immunoglobulin Expression. J. Immunol. 1978; 121: 641
   PubMed Web of Science ®Google Scholar
• Boyd A. W., Goding J. W., Schrader J. W. The Regulation of Growth and Differentiation of a Murine B Cell Lymphoma. I. Lipopolysaccharide-induced Differentiation. J. Immunol. 1981; 126: 2461
   Google Scholar
• Boyd A. W., Schrader J. W. The Regulation of Growth and Differentiation of a Murine B Cell Lymphoma. II. The Inhibition of WEHI 231 by Anti-immunoglobulin Antibodies. J. Immunol. 1981; 126: 2466
   PubMed Web of Science ®Google Scholar
• McCormack J. E., Pepe V. H., Kent R. G., Dean M., Marshak-Rothstein A., Sonenshein G. E. Specific Regulation of c-myc Oncogene Expression in a Murine B-Cell Lymphoma. Proc. Natl. Acad. Sci. USA 1984; 81: 5546
   PubMed Web of Science ®Google Scholar
• Isakson P. C., Pure E., Uhr J. W., Vitetta E. S. Induction of Proliferation and Differentiation of Neoplastic B Cells. B Lymphocytes in the Immune Response: Functional, Developmental and Interactive Properties, D. E. Klinman, I. Scher, E. S. Vitetta. Elsevier North Holland, New York 1981; 501
   Google Scholar
• Brooks K. H., Uhr J. W., Krammer P. H., Vitetta E. S. Lymphokine-induced IgM Secretion by Clones of Neoplastic B Cells (BCL1). Nature 1983; 302: 825
   PubMedGoogle Scholar
• Rohrer J. W., Lynch R. G. Antigen-specific Regulation of Myeloma Cell Differentiation in vivo by Carrier-specific T Cell Factors and Macrophages. J. Immunol 1978; 120: 1066
   Google Scholar
• Lynch R. G., Graff R., Sirisinha S., Simms E. S., Eisen H. N. Myeloma Proteins as Tumor Specific Transplantation Antigens. Proc. Natl. Acad. Sci. USA 1972; 69: 1540
   PubMed Web of Science ®Google Scholar
• Meinke G. C., McConakey P. J., Spiegelberg H. L. Suppression of Plasmacytoma Growth in Mice by Immunization with Myeloma Protein. Fed. Proc. 1974; 33: 792
   Google Scholar
• Sugai S., Palmer D. W., Talal N., Witz I. P. Protective and Cellular Immune responses to Idiotypic Determinants on Cells from a Spontaneous Lymphoma of NZB/NZW Mice. J. Exp. Med. 1974; 140: 1547
   PubMedGoogle Scholar
• Eisen H. N., Sakato N., Hall S. J. Myeloma Proteins as Tumor-specific Antigens. Transplant. Proc. 1975; 7: 209
   PubMed Web of Science ®Google Scholar
• Freedman P., Autry J. R., Tokuda S., Williams R. C. Tumor Immunity Induced by Pre-immunization with BALB/c Mouse Myeloma Protein. J. Natl. Cancer Inst. 1976; 45: 735
   Google Scholar
• Haughton G., Lanier L. L., Babcock G. F., Lynes M. A. Antigen Induced Murine B Cell Lymphomas II. Exploitation of the Surface Idiotype as Tumor Specific Antigen. J. Immunol. 1978; 121: 2358
   PubMed Web of Science ®Google Scholar
• Stevenson G. T., Elliott E., Stevenson F. K. Idiotypic Determinants on the Surface of Neoplastic Lymphocytes: A Therapeutic Approach. Fed. Proc. 1977; 36: 2268
   PubMedGoogle Scholar
• Krolick K. A., Isakson P. C., Uhr J. W., Vitetta E. S. BCL1, A Murine Model for Chronic Lymphocytic Leukemia; Use of the Surface Immunoglobulin Idiotype for Detection and Treatment of a Tumor. Immunol. Rev. 1979; 48: 81
   PubMed Web of Science ®Google Scholar
• Perek Y., Hurwitz E., Burowsky B. Immunotherapy of a Murine B Cell Tumor with Antibodies and F(ab)2 Fragments Against Idiotypic Determinants of Its Cell Surface IgM. J. Immunol. 1983; 131: 1600
   Google Scholar
• Flood P. M., Phillips C., Taupier M., Schrieber H. Regulation of Myeloma Growth in vitro by Idiotype-specific T Lymphocytes. J. Immunol. 1980; 124: 424
   PubMed Web of Science ®Google Scholar
• Beatty P. G., Kim B. S., Rowley D. W., Coppelson L. W. Antibody Against the Antigen Receptor of a Plasmacytoma Prolongs Survival of Mice Bearing that Tumor. J. Immunol 1976; 116: 1391
   Google Scholar
• Puskas E., Uher F., Gergely J., Bazin H. An Experimental Immunocytoma Model in LOU/M/Wsl x CFY F1 Rats: Neoplastic Cells as Targets of the Hosts Immune Apparatus. Immunology 1984; 52: 547
   Google Scholar
• Thielmans K., Rothbard J. B., Levy S., Levy R. Syngeneic Antiidiotypic Immune Responses to a B Cell Lymphoma. Comparision between Heavy Chain Hypervariable Region Peptides and Intact Ig as Immunogens. J. Exp. Med. 1985; 162: 19
   Google Scholar
• Miller R. A., Maloney D. G., Warnke R., Levy R. Treatment of B Cell Lymphoma with Monoclonal Anti-idiotype Antibody. N. Engl. J. Med. 1982; 306: 527
   Google Scholar
• Hannestad K., Kao M. S., Eisen H. N. Cell-bound Myeloma Proteins on the Surface of Myeloma Cells: Potential Targets for the Immune System. Proc. Natl. Acad. Sci. USA 1972; 69: 2295
   PubMedGoogle Scholar
• Rohrer J. W., Vasa K., Lynch R. G. Myeloma Cell Immunoglobulin Expression During in Vivo Growth in Diffusion Chambers: Evidence for Repetitive Cycles of Differentiation. J. Immunol. 1977; 119: 861
   PubMed Web of Science ®Google Scholar
• Tsao B. P., Aldo-Benson M. A. Central Suppression of Monoclonal B Cells: DNP-MGG Supresses Proliferation and Immunoglobulin Synthesis in Anti-DNP-Secreting Hybridoma and Myeloma Cells. Cell. Immunol. 1984; 88: 96
   Google Scholar
• Saunders G. C., Wilder M. A. Repetitive Maturation Cycles in a Cultured Mouse Myeloma. J. Cell. Biol. 1971; 51: 344
   Google Scholar
• Russell J. H., Hale A. H., Ginns L. C., Eisen H. N. Periodic Loss of Reactivity of a Myeloma Tumor with Cytotoxic Thymus-derived Lymphocytes. Proc. Natl. Acad. Sci. USA 1978; 75: 41
   Google Scholar
• Frondoza C. G., Trivedi S. M., Humphrey R. L. Temporary Disappearance (“eclipse”) of LPC-1 Plasmacytoma M-component Synthesis Following Tumor Cell Transfer. Cancer Res. 1979; 39: 2497
   Google Scholar
• Kubagawa H., Vogler L. B., Capra J. D., Conrad M. E., Lawton A. R., Cooper M. D. Studies on the Clonal Origin of Multiple Myeloma: Use of Individually-specific (Idiotype) Antibodies to Trace the Oncogenic Event to Its Earliest Point of Expression in B-cell Differentiation. J. Exp. Med. 1979; 150: 792
   PubMed Web of Science ®Google Scholar
• Durie B. G. M. The Malignant Cell in Multiple Myeloma and Waldenstroms Macroglobulinemia. Topics in Aging Research in Europe 1985; 5: 25
   Google Scholar
• Paraf A., Gueron-Marchand C., Aubrey J., Dubert J. M. Inhibition of Murine Plasmacytoma Tumors with Antibody Activity by Their Specific Antigens. Ann. Immunol. (Inst. Pasteur) 1974; 126C: 411
   Google Scholar
• Barnhill C. W., Ghanta V. K., Hiramoto R. N., Yielding K. L. Immunologic Suppression of DNA Synthesis in MOPC-104E Plasmacytoma Cells. Proc. Soc. Exp. Biol. Med. 1976; 153: 107
   Google Scholar
• Osborne D. P., Katz D. H. The Allogeneic Effect on Tumor Growth. I. Inhibition of a Murine Plasmacytoma, MOPC-315, by the Graft-vs-Host Reaction. J. Immunol. 1977; 118: 1441
   Google Scholar
• Bosma M. L., Bosma G. C. Prevention of IgG2a Production as a Result of Allotype Specific Interaction Between T and B Cells. J. Exp. Med. 1977; 145: 743
   Google Scholar
• Kans J., D'Ottavio R., Kohler H. Mechanism of Neonatal Idiotype Suppression. III. Delayed Maturation of Plasmacytoma Stem Cells in Neonatally Suppressed Hosts. J. Immunol. 1981; 127: 509
   Google Scholar
• Abbas A., Klaus G. G. B. Inhibition of Antibody Production in Mouse Plasmacytoma Cells by Antigens. Eur. J. Immunol. 1977; 7: 667
   PubMedGoogle Scholar
• Kim B. A. Mechanisms of Idiotype Suppression. I. In Vitro Generation of Idiotype-specific Suppressor T Cells by Anti-idiotype Antibodies and Specific Antigen. J. Exp. Med. 1979; 149: 1371
   Google Scholar
• Abbas A. Inhibition of Antibody Production in Plasmacytoma Cells. III. Interactions of Suppressive and Non-suppressive DNP-conjugates with MOPC-315 Cells. J. Immunol. 1979; 122: 1791
   PubMedGoogle Scholar
• Bankert R. B., Mayers G. L., Pressman D. Clearance and Re-expression of a Myeloma Cell's Antigen-binding Receptors Induced by Ligands Known to be Immunogenic or Tolerogenic for Normal B Lymphocytes: A Model to Study Membrane Events Associated with B Cell Tolerance. Eur. J. Immunol. 1978; 8: 512
   Google Scholar
• Boyd A. W., Schrader J. W. Mechanism of Effector-cell Blockade. I. Antigen-induced Suppression of Ig Synthesis in a Hybridoma Cell Line, and Correlation with Cell-associated Antigen. J. Exp. Med. 1980; 151: 1436
   PubMedGoogle Scholar
• Kresina T. F., Baine Y., Nisonoff A. Adoptive Transfer of Resistance to Growth of an Idiotype-Secreting Hybridoma by T Cells from Idiotypically Suppressed Mice. J. Immunol. 1983; 130: 1478
   PubMedGoogle Scholar
• Abbas A. K. Immunologic Regulation of Lymphoid Tumor Cells: Model Systems for Lymphocyte Function. Adv. Immunol 1982; 32: 301
   Google Scholar
• Lynch R. G., Milburn G. L. Murine Plasmacytoma MOPC 315 as a Tool for the Analysis of Network Regulation. The Biology of Idiotypes, M. I. Greene, A. Nisonoff. Plenum, New York 1984; 299
   Google Scholar
• Daley M. J., Gebel H. M., Lynch R. G. Idiotype-specific Transplantation Resistance to MOPC-315: Abrogation by Post-immunization Thymectomy. J. Immunol. 1978; 120: 1620
   PubMed Web of Science ®Google Scholar
• Odermatt B. O., Perlmutter R., Lynch R. G. Molecular Heterogeneity and Fine Specificity of BALB/c Antibodies Elicited by Isologous Myeloma Protein. Eur. J. Immunol. 1978; 8: 858
   PubMedGoogle Scholar
• Milburn G. L., Lynch R. G. Anti-idiotypic Regulation of IgA Expression in Myeloma Cells. Molec. Immunol. 1983; 20: 931
   PubMedGoogle Scholar
• Rohrer J. W., Odermatt B. O., Lynch R. G. Immunoregulation of Murine Myeloma: Isologous Immunization with M315 Induces Idiotype-specific T Cells that Suppress IgA Secretion by MOPC-315 Cells in Vivo. J. Immunol. 1979; 122: 2011
   PubMedGoogle Scholar
• Milburn G. L., Lynch R. G. Immunoregulation of Murine Myeloma in Vitro. J. Exp. Med. 1982; 155: 852
   PubMed Web of Science ®Google Scholar
• Parslow T. G., Milburn G. L., Lynch R. G., Granner D. K. Suppressor T Cell Action Inhibits the Expression of an Excluded Immunoglobulin Gene. Science 1983; 220: 1389
   Google Scholar
• Milburn G. L., Parslow T. G., Goldenberg C., Granner D. K., Lynch R. G. Idiotype-specific T Cell Suppression of Light Chain mRNA Expression in MOPC-315 Cells is Accompanied by a Post-transcriptional Inhibition of Heavy Chain Expression. J. Cell Mol. Immunol. 1984; 1: 115
   Google Scholar
• Springer T. A., Thompson W. S., Miller L. J., Schmalsteiz F. C., Anderson D. C. Inherited Deficiency of the Mac-1, LFA-1, p150, p95 Glycoprotein Family and Its Molecular Basis. J. Exp. Med. 1984; 160: 1901
   PubMed Web of Science ®Google Scholar
• Maloy W. L., Coligan J. E. Is B2-microglobulin Required for MHC Class I Heavy Chain Expression?. Immunol. Today. 1985; 6: 263
   Google Scholar
• Bothwell A., Paskind M., Schwartz R., Sonenshein G., Gefter M., Baltimore D. Dual Expression of Λ Genes in the MOPC-315 Plasmacytoma. Nature 1981; 290: 65
   Google Scholar
• Ju S.-T., Pinto D., Dorf M. E. Lack of Isotype Exclusion and Expression of Aberrant Lambda Light Chain on Secreted MOPC-315 Myeloma Proteins. Mol. Immunol. 1986; 23: 79
   Google Scholar
• Hozumi N., Wu G., Murialdo H., Baumal R., Mosman T., Winberry L., Marks A. Arrangement of 2 Light Chain Genes in Mutant Clones of the MOPC-315 Mouse Myeloma Cells. J. Immunol. 1982; 129: 260
   Google Scholar